Capsular polysaccharide-protein conjugate vaccines

Drug Discovery Today

Volumn 1, Issue 9, 1996, Pages 381-387

  Sood, Ramesh K ^a   Fattom, Ali ^a   Pavliak, Viliam ^a   Naso, Robert B ^a  

^a Nabi Biopharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001102986     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/1359-6446(96)10032-5     Document Type: Review

References (64)

1. Dochez, A.R. and Avery, O.T. (1917) J. Exp. Med. 26, 477-493
2. Heidelberger, M. and Avery, O.T. (1923) J. Exp. Med. 38, 73-79
3. MacLeod, C.M. et al. (1945) J. Exp. Med. 82, 445-465
4. Heidelberger, M. et al. (1946) J. Exp. Med. 83, 301-320
5. Robbins, J.B. (1978) Immunochemistry 15, 839-854
6. Jennings, H.J. (1990) Curr. Top. Microbiol. Immunol. 150, 97-127
7. Gotschlich, E.C., Goldschneider, I., Lepow, M.L. and Gold, R. (1977) in Antibodies in Human Diagnosis and Therapy (Haber, E. and Krause, R.M., eds), pp. 391-402, Raven
8. Winston, D.J. et al. (1983) Arch. Intern. Med. 143, 1735-1737
9. Bolan, G. et al. (1986) Ann. Intern. Med. 104, 1-6
10. Reingold, A.L. et al. (1985) Lancet ii, 114-118
11. Heidelberger, M. et al. (1950) J. Immunol. 65, 535-541
12. Peltola, H. et al. (1977) Pediatrics 60, 730-737
13. Austrian, R. (1985) Ann. Inst. Pasteur Microbiol. 136B, 295-307
14. Robbins, J.B., Parke, J.C., Schneerson, R. and Whisnant, J.K. (1973) Pediatr. Res. 7, 103-110
15. Douglas, R.M., Paton, J.C., Duncan, S.J. and Hansman, D.J. (1983) J. Infect. Dis. 148, 131-137
16. Avery, O.T. and Goebel, W.F. (1929) J. Exp. Med. 50, 521-533
17. Goebel, W.F. (1939) J. Exp. Med. 69, 353-364
18. Stein, K.E. (1994) Int. J. Technol. Assess. Health Care 10, 167-176
19. Santosham, M. et al. (1991) New Engl. J. Med. 324, 1767-1772
20. Black, S.B. et al. (1991) Pediatr. Infect. Dis. J. 10, 97-104
21. Seppala, I. and Makela, O. (1989) J. Immunol. 143, 1259-1264
22. Jorbeck, H.H.A., Svenson, S.B. and Lindberg, A.A. (1981) Infect. Immun. 32, 497-502
23. Szu. S. et al. (1989) Infect. Immun. 57, 3823-3827
24. Peeters, C.C.A.M. et al. (1991) J. Immunol. 146, 4308-4316
25. Paoletti, L.C. et al. (1992) J. Clin. Invest. 89, 203-209
26. Anderson, P.W. et al. (1986) J. Immunol. 137, 1181-1186
27. Anderson, P. (1983) Infect. Immun. 39, 233-238
28. Anderson, P., Pichichero, M.E. and Insel, R.A. (1985) J. Clin. Invest. 76, 52-59
29. Fattom, A. et al. (1990) Infect. Immun. 58, 2367-2374
30. Fattom, A. et al. (1992) Infect. Immun. 60, 584-589
31. Chu, C. et al. (1983) Infect. Immun. 40, 245-256
32. Marburg, S. et al. (1986) J. Am. Chem. Soc. 108, 5282-5287
33. Evenberg, D. et al. (1992) J. Infect. Dis. 165 (Suppl. 1), S152-S155
34. Paton, J. et al. (1991) Infect. Immun. 59, 2297-2304
35. Lucak, M., Pier, G.B. and Collier, R.J. (1988) Infect. Immun. 56, 3095-3098
36. Jennings, H.J. and Lugowski, C. (1981) J. Immunol. 127, 1011-1018
37. Porro, M. et al. (1985) Mol. Immunol. 22, 907-919
38. Beuvery, E.C., Roy, R., Kanhai, V. and Jennings, H.J. (1986) Dev. Biol. Stand. 65, 197-204
39. Jennings, H.J. (1992) J. Infect. Dis. 165 (Suppl. 1), S156-S159
40. Gordon, L.K. (1986) US Patent 4,619,828
41. Marburg, S., Tolman, R.L. and Kniskern, P.J. (1989) US Patent 4,882,317
42. Dick, W.E., Jr and Beurret, M. (1989) in Contributions to Microbiology and Immunology (Vol. 10) (Cruse, J.M. and Lewis, R.E., Jr, eds), pp. 48-114, S. Karger
43. Moreau, M. et al. (1990) Carbohydr. Res. 201, 285-297
44. Bundle, D.R., Smith, I.C.P. and Jennings, H.J. (1974) J. Biol. Chem. 249, 2275-2281
45. Wessels, M.R. et al. (1987) J. Biol. Chem. 262, 8262-8267
46. Fattom, A. et al. (1995) Vaccine 13, 1288-1293
47. Jennings, H.J. and Sood, R.K. (1994) in Neoglycoconjugates: Preparation and Applications (Lee, Y.C. and Lee, R.T., eds), pp. 325-371, Academic Press
48. Aplin, J.D. and Wriston, J.C., Jr (1981) CRC Crit. Rev. Biochem. 10, 259-306
49. Stowell, C.P. and Lee, Y.C. (1980) Adv. Carbohydr. Chem. Biochem. 37, 225-281
50. Robbins, J.B. and Schneerson, R. (1990) J. Infect. Dis. 161, 821-832
51. Schneerson, R. et al. (1986) Infect. Immun. 52, 519-528
52. Schneerson, R. et al. (1980) J. Exp. Med. 152, 361-376
53. Austrian, R. (1981) Rev. Infect. Dis. 3, S51-S57
54. Robbins, J.B. et al. (1983) J. Infect. Dis. 148, 1136-1159
55. Golding, B. (1991) in Topics in Vaccine Adjuvant Research (Spriggs, D.R. and Koff, W.C., eds), pp. 25-37, CRC Press
56. Molrine, D.C. et al. (1995) Ann. Intern. Med. 123, 828-834
57. Cho, Y.H., Fries, L., Naso, R. and Fattom, A. (1995) 35th ICAAC, San Francisco, p. 172 (Abstr.)
58. Peeters, C.C.A. et al. (1991) Infect. Immun. 59, 3504-3510
59. Barington, T. et al. (1993) Infect. Immun. 61, 432-438
60. Barington, T. et al. (1994) Infect. Immun. 62, 9-14
61. Fattom, A. et al. (1993) 33rd ICAAC, New Orleans, p. 331 (Abstr.)
62. Fattom, A. et al. (1995) 95th American Society of Microbiology General Meeting, Washington DC, p. 275 (Abstr.)
63. Fattom, A. et al. Infect. Immun. (in press)
64. Basham, L. et al. (1996) 96th American Society of Microbiology General Meeting, New Orleans, p. 534 (Abstr.)